Hagens berman, national trial attorneys, encourages longtime shareholders in regeneron pharmaceuticals (regn) to contact its attorneys: firm investigating possible breach of fiduciary duties

San francisco, july 2, 2020 /prnewswire/ -- hagens berman urges longtime shareholders in regeneron pharmaceuticals, inc. (nasdaq: regn) to submit their losses now. the firm is investigating whether regeneron's directors breached their fiduciary duties. relevant holding period: at least...
REGN Ratings Summary
REGN Quant Ranking